Article
NIH, Industry, And The Translational Science Revolution
December 21, 2011
By Sara Gambrill, Life Science Leader magazine
The National Institutes of Health's (NIH's) reputation has been built, in large part, on discoveries made during basic science research — original insights about pathways, receptors, and targets for drugs. These discoveries have led to a significant percentage of new drug approvals in most of the major classes of drugs. However, Francis Collins, M.D., Ph.D., director of NIH, wants to make clear, "NIH doesn't only do basic science. A little more than half our budget is devoted to basic science, but a substantial fraction goes to applied science. And, much of this applied science has only been successful because of partnerships with industry." NIH wants its relationship with industry to be even more productive.Used with permission from Life Science Leader magazine.
Register Today. It's Fast And Free.
The content you requested is only available to registered users of Bioresearch Online. By registering now, you'll get exclusive access to this piece of content and thousands of addtional articles and product reviews across our entire network of sites.
Already Registered? Sign In.
